Arno Therapeutics Inc. / D'Assoro AB / Hiscox / GE / Ligand / Proc Natl Acad Sci U S A / Google / Obr AE / Beristain AG / Fuqua SA / BioMed Central Ltd. / EPIC / Creative Commons / /
Country
Oesterreich / Jordan / United States / / /
Event
Product Issues / /
Facility
Pike JW / Lange laboratory / scaffolding PELP1 / clinic Post / laboratory of CAL. Acknowledgements The / laboratory of C. Brisken / University of Minnesota / /
IndustryTerm
organ site / target-gene products / breast cancer therapy / breast cancer prevention / pharmaceutical / prostate cancer treatment / breast cancer treatment / therapy for PR-positive breast cancer / genomic and transcriptional networks / treatment of breast cancer / therapy for progesterone receptor-positive breast cancer / therapy for human breast cancer / therapy for locally advanced or primary breast cancer / online submission / /
MedicalCondition
advanced endocrine-resistant breast cancers / Endocr Relat Cancer / untreated metastatic breast carcinoma / positive tumors / hormone-dependent cancers / DF / ovarian cancer / luminal tumors / early tumor / JE / primary breast cancer / mammary gland tumors / early breast cancer / routine luminal cancer / luminal-B-type tumors / human tumors / J Cancer / hormone receptor-positive breast cancer / endocrine-resistant disease / tamoxifen-resistant human breast cancer / different breast cancer / endometrial cancer / progestin-induced mammary tumor / human diseases / breast tumor / breast cancer Luminal breast tumors / aggressive cancer / prostate cancer / murine mammary tumor / luminal breast cancer / human breast cancer / advanced breast cancer / breast cancer / human breast tumours / individual tumor / tumor / high ERBB2-expressiong tumors / breast cancers / improved breast cancer / individual tumors / cancer / PR-positive breast cancer / tumors / interferon/inflammation / luminal subtype human breast cancer / luminal breast cancers / achieved tumor / progesterone receptor-positive breast cancer / Clin Breast Cancer / tumour metastasis / breast carcinogenesis / breast tumors / Bull Cancer / stable disease / reproductive cancers / inflammation / inflammatory / /
Masonic Cancer Center / Endocrine Society / Department of Pharmacology / National Cancer Institute of Canada Clinical Trials Group / Department of Medicine / University of Minnesota / /
Person
Christy R Hagan / Ernst Schering / Andrea R. Daniel / Ann Oncol / Carol A Lange / Michael Freeman / /
Position
driver / Tickle Family Land Grant Endowed Chair / Director of The Cancer Biology Training Grant / Butler / Scott MP / Editor-in-Chief / Bishop / Hunter / Chlebowski RT / Sluss PM / Fisher / /
Molecular determinants of context-dependent progesterone receptor action in breast cancer